Form 4: RenovoRx CFO Acquires Shares, RSUs Vest

RenovoRx Chief Financial Officer Mark Voll reported the acquisition of 25,000 common shares and the vesting of 8,823 restricted stock units.

Summary

• Mark Voll, Chief Financial Officer of RenovoRx, Inc., reported transactions on May 19, 2026.
• Voll acquired 25,000 shares of common stock through open market purchases at an average price of $0.7876 per share.
• Following these purchases, Voll beneficially owns 97,200 shares of common stock, held indirectly through the Voll Family Trust.
• Additionally, 8,823 restricted stock units (RSUs) vested as of April 30, 2026, out of a total grant of 58,953 RSUs for future service.
• There are 50,130 unvested RSUs remaining.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing due to the CFO's direct stock purchase, indicating personal investment and confidence, though it does not represent new company performance data.

Positives

• The Chief Financial Officer's open market purchase of company stock signals confidence in the company's future prospects.
• Vesting of restricted stock units indicates continued commitment and progress towards performance-based compensation for the CFO.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. However, the CFO's stock purchase may imply a positive outlook.

Industry Context

StockSavvy.ai notes that insider purchases, particularly by a Chief Financial Officer, are often viewed as a positive signal by the market, suggesting a belief in the company's intrinsic value and future performance within the biotechnology or pharmaceutical sector.

Stakeholder Impact

• Shareholders may view the CFO's purchase as a positive signal of confidence in the company's future.
• Employees may be encouraged by leadership's investment in the company.

Key Dates

Recommendation

The filing reports routine insider transactions (stock purchase and RSU vesting) and does not contain new financial performance data or strategic updates that would warrant a change in investment recommendation. The CFO's purchase is a positive signal but not sufficient to drive a strong buy or sell decision on its own.

Keywords

RenovoRx, RNXT, Form 4, Insider Trading, Stock Purchase, RSU Vesting, Chief Financial Officer, Beneficial Ownership